Report cover image

Global Controlled Release Drug Delivery Market Report and Forecast 2024-2032

Publisher Expert Market Research
Published Feb 06, 2024
Length 140 Pages
SKU # EMAR18558238

Description

Global Controlled Release Drug Delivery Market Report and Forecast 2024-2032


Global Controlled Release Drug Delivery Market Report and Forecast 2024-2032

Global Controlled Release Drug Delivery Market Outlook

The global controlled release drug delivery market size was valued at USD 54.8 billion in 2023, driven by rising demand for patient-centric solutions across the globe. The market size is anticipated to grow at a CAGR of 10.4 % during the forecast period of 2024-2032 to achieve a value of USD 134 billion by 2032.

Controlled Release Drug Delivery: Introduction

Controlled release drug delivery is a sophisticated technology that precisely releases medication into the body at a predetermined rate, duration, and location. This approach optimizes therapeutic effectiveness, minimizes side effects, and enhances patient convenience and compliance by reducing the frequency of dosing. Commonly used in various forms such as pills, injections, or implants, controlled release systems are designed to maintain consistent drug levels in the bloodstream, ensuring a more stable and targeted treatment outcome.

Key Trends in the Global Controlled Release Drug Delivery Market

There's a continuous push for advanced technologies in drug formulation and design, such as microencapsulation, nano-based delivery systems, and biodegradable polymers, aiming to achieve more precise and targeted drug release profiles.

The market is increasingly focusing on enhancing patient convenience and adherence to treatment regimens. This includes the development of once-daily dosage forms and devices that are less invasive and more user-friendly.

Controlled release systems are particularly beneficial for managing chronic conditions such as diabetes, hypertension, and mental health disorders, where maintaining stable drug levels is crucial. The market is expanding to address the growing prevalence of these diseases.

The integration of controlled release technology with biologic drugs is a growing trend, aimed at extending the half-life of these high-potency drugs and reducing the frequency of dosing.

There is a growing emphasis on meeting stringent regulatory standards to ensure the safety, efficacy, and quality of controlled release products, driving innovation in manufacturing processes and quality control.

Emerging markets are increasingly adopting controlled release technologies, driven by rising healthcare expenditure, improving healthcare infrastructure, and a growing focus on enhancing the quality of life.

Global Controlled Release Drug Delivery Market Segmentation

Market Breakup by Technology
  • Wurster Technique
  • Coacervation
  • Micro Encapsulation
  • Implants
  • Transdermal
  • Targeted Delivery
  • Others
Market Breakup by Mechanism
  • Polymer Based Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Feedback Regulated Drug Delivery Systems
  • Activation-modulated Drug Delivery Systems
  • Osmotic Pressure Activated
  • Hydrodynamic Pressure Activated
  • Vapor Pressure Activated
  • Mechanically Activated
  • Magnetically Activated
  • Chemically Activated
  • pH Activated
  • Hydrolysis Activated
  • Enzyme Activated
Market Breakup by Applications
  • Metered Dose Inhalers
  • Injectable
  • Transdermal and Ocular Patches
  • Infusion Pumps
  • Oral Controlled-drug Delivery Systems
  • Drug Eluting Stents
Market Breakup by End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
  • Others
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Controlled Release Drug Delivery Market Overview

North America dominates in innovation and adoption of controlled release technologies, particularly in the U.S. and Canada. The region benefits from advanced healthcare infrastructure, substantial investments in pharmaceutical R&D, and a robust regulatory framework supporting the development of novel drug delivery systems.

Europe shows a strong focus on quality healthcare and patient-centric drug development, with countries like Germany, the UK, and France leading in pharmaceutical innovation. The market is supported by stringent regulatory standards and a high emphasis on advanced drug delivery research.

Asia-Pacific is experiencing rapid growth, especially in China, India, and Japan, driven by increasing healthcare expenditure, growing pharmaceutical sectors, and rising demand for sophisticated healthcare solutions. The region is becoming a hub for pharmaceutical manufacturing and R&D, though varying regulatory landscapes can impact market dynamics.

Global Controlled Release Drug Delivery Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline plc (GSK)
  • Merck & Co., Inc.
  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • Alkermes plc.
  • UCB S.A.
  • Vectura Group plc.
  • Coating Place, Inc.
  • Skyepharma Production S.A.
  • Capsugel
  • Depomed, Inc.
  • Aradigm Corporation
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.

Table of Contents

140 Pages
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Controlled Release Drug Delivery Market Overview
3.1 Global Controlled Release Drug Delivery Market Historical Value (2017-2023)
3.2 Global Controlled Release Drug Delivery Market Forecast Value (2024-2032)
4 Global Controlled Release Drug Delivery Market Landscape
4.1 Global Controlled Release Drug Delivery Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Controlled Release Drug Delivery Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
5 Global Controlled Release Drug Delivery Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Controlled Release Drug Delivery Market Segmentation
6.1 Global Controlled Release Drug Delivery Market by Technology
6.1.1 Market Overview
6.1.2 Wurster Technique
6.1.3 Coacervation
6.1.4 Micro Encapsulation
6.1.5 Implants
6.1.6 Transdermal
6.1.7 Targeted Delivery
6.1.8 Others
6.2 Global Controlled Release Drug Delivery Market by Mechanism
6.2.1 Market Overview
6.2.2 Polymer Based Systems
6.2.3 Micro Reservoir Partition Controlled Drug Delivery Systems
6.2.4 Feedback Regulated Drug Delivery Systems
6.2.5 Activation-modulated Drug Delivery Systems
6.2.5.1 Osmotic Pressure Activated
6.2.5.2 Hydrodynamic Pressure Activated
6.2.5.3 Vapor Pressure Activated
6.2.5.4 Mechanically Activated
6.2.5.5 Magnetically Activated
6.2.6 Chemically Activated
6.2.6.1 pH Activated
6.2.6.2 Hydrolysis Activated
6.2.6.3 Enzyme Activated
6.3 Global Controlled Release Drug Delivery Market by Applications
6.3.1 Market Overview
6.3.2 Metered Dose Inhalers
6.3.3 Injectable
6.3.4 Transdermal and Ocular Patches
6.3.5 Infusion Pumps
6.3.6 Oral Controlled-drug Delivery Systems
6.3.7 Drug Eluting Stents
6.4 Global Controlled Release Drug Delivery Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgical Centers
6.4.4 Cancer Research Institutes
6.4.5 Others
6.5 Global Controlled Release Drug Delivery Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Controlled Release Drug Delivery Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Controlled Release Drug Delivery Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Controlled Release Drug Delivery Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Controlled Release Drug Delivery Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Controlled Release Drug Delivery Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Supplier Landscape
18.1 Johnson & Johnson
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisition
18.1.5 Certifications
18.2 Novartis AG
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisition
18.2.5 Certifications
18.3 Pfizer Inc.
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisition
18.3.5 Certifications
18.4 GlaxoSmithKline plc (GSK)
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisition
18.4.5 Certifications
18.5 Merck & Co., Inc.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisition
18.5.5 Certifications
18.6 Bristol Myers Squibb Company
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisition
18.6.5 Certifications
18.7 Eli Lilly and Company
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisition
18.7.5 Certifications
18.8 Alkermes plc.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisition
18.8.5 Certifications
18.9 UCB S.A.
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisition
18.9.5 Certifications
18.10 Vectura Group plc.
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisition
18.10.5 Certifications
18.11 Coating Place, Inc.
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisition
18.11.5 Certifications
18.12 Skyepharma Production S.A.
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisition
18.12.5 Certifications
18.13 Capsugel
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisition
18.13.5 Certifications
18.14 Depomed, Inc.
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisition
18.14.5 Certifications
18.15 Aradigm Corporation
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisition
18.15.5 Certifications
19 Global Controlled Release Drug Delivery Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us